home / stock / dbvt / dbvt quote
Last: | $4.395 |
---|---|
Change Percent: | 0.0% |
Open: | $4.46 |
Close: | $4.395 |
High: | $4.46 |
Low: | $4.26 |
Volume: | 6,288 |
Last Trade Date Time: | 02/14/2025 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.395 | $4.46 | $4.395 | $4.46 | $4.26 | 6,288 | 02-17-2025 |
$4.395 | $4.46 | $4.395 | $4.46 | $4.26 | 6,288 | 02-14-2025 |
$4.35 | $4.37 | $4.35 | $4.37 | $4.05 | 10,814 | 02-13-2025 |
$4.1184 | $4.15 | $4.1184 | $4.3799 | $4.1184 | 6,051 | 02-12-2025 |
$4.19 | $4.06 | $4.19 | $4.53 | $4.06 | 15,617 | 02-11-2025 |
$4.195 | $4.1 | $4.195 | $4.2429 | $4 | 10,573 | 02-10-2025 |
$4.12 | $4.3 | $4.12 | $4.45 | $4.1 | 49,985 | 02-07-2025 |
$4.4 | $4.48 | $4.4 | $4.49 | $4.28 | 17,801 | 02-06-2025 |
$4.58 | $4.4 | $4.58 | $4.6299 | $4.39 | 12,451 | 02-05-2025 |
$4.53 | $4.44 | $4.53 | $4.53 | $4.29 | 293,771 | 02-04-2025 |
$4.06 | $4.01 | $4.06 | $4.06 | $3.8101 | 12,140 | 02-03-2025 |
$4.225 | $4.28 | $4.225 | $4.54 | $3.8001 | 34,774 | 01-31-2025 |
$4.26 | $4.23 | $4.26 | $4.26 | $4.1609 | 5,902 | 01-30-2025 |
$4.22 | $4.3 | $4.22 | $4.45 | $4.22 | 5,456 | 01-29-2025 |
$4.48 | $4.35 | $4.48 | $4.5 | $4.1916 | 12,344 | 01-28-2025 |
$4.52 | $4.46 | $4.52 | $4.52 | $4.1533 | 17,964 | 01-27-2025 |
$4.34 | $4.56 | $4.34 | $4.58 | $4.1 | 36,374 | 01-24-2025 |
$4.4 | $4.47 | $4.4 | $4.5962 | $4.38 | 18,009 | 01-23-2025 |
$4.74 | $4.6 | $4.74 | $4.74 | $4.54 | 16,144 | 01-22-2025 |
$4.52 | $4.59 | $4.52 | $4.72 | $4.48 | 36,654 | 01-21-2025 |
News, Short Squeeze, Breakout and More Instantly...
DBV Technologies S.A. Company Name:
DBVT Stock Symbol:
NASDAQ Market:
DBV Technologies S.A. Website:
Châtillon, France, January 8 th , 2025 DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study EPITOPE OLE data demonstrates continued improvement in treatment benefit of VIASKIN® Peanut patch in toddlers 1 – 3 years ...
Châtillon, France, December 11 th , 2024 DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old DBV and FDA aligned on key study design elements for the COMFORT Toddlers study in 1 –...
Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2024 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 ...